AI Support Improves Breast Cancer Detection Accuracy in Mammography
By Elana Gotkine HealthDay Reporter
MONDAY, July 14, 2025 -- Artificial intelligence (AI) support improves radiologists' breast cancer detection accuracy when reading mammograms, according to a study published online July 8 in Radiology.
Jessie J.J. Gommers, Ph.D., from the Radboud University Medical Center in Nijmegen, Netherlands, and colleagues compared radiologist performance and visual search patterns when reading screening mammograms with and without an AI decision support system in a retrospective mutireader multicase study involving 12 breast screening radiologists with four to 32 years of experience from 10 institutions. Screening mammograms acquired between September 2016 and May 2019 were assessed unaided and with a U.S. Food and Drug Administration-approved, European Commission-marked AI decision support system, which assigns a region suspicion score from 1 to 100.
The study included mammography examinations from 150 women (75 with breast cancer and 75 without breast cancer). The researchers found that the mean area under the receiver operating characteristic curve was higher with AI support (unaided, 0.93; AI-supported, 0.97). No evidence was seen for a difference in mean sensitivity, specificity, or reading time. Lower breast fixation coverage was seen with AI support (11.1 versus 9.5 percent of the breast area), while higher fixation time in the lesion region was observed (4.4 versus 5.4 seconds). No evidence was seen for a difference in time to first fixation within the lesion region.
"AI not only helped radiologists focus on the right cases but also directed their attention to the most relevant regions within those cases, suggesting a meaningful role for AI in improving both performance and efficiency in breast cancer screening," Gommers said in a statement
Several authors disclosed ties to the medical device industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Risk for Death From Prostate Cancer Low With Guideline Care for Nonmetastatic Disease
MONDAY, July 14, 2025 -- Men with nonmetastatic prostate cancer receiving guideline-concordant care have a much higher risk for death from causes other than prostate cancer...
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.